Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.


Dr Schulz studied medicine in Aachen (Germany), and came to the UK in 1996. She completed her general medical training in Glasgow before coming to Oxford to do a D.Phil. in the Stroke Prevention Research Unit as a Wellcome Clinical Research Fellow. She returned to Scotland to complete her Neurology training and then came back to Oxford after having been awarded an NIHR Clinician Scientist Award.

Awards Training and Qualifications

  • 2008- 2013 NIHR Clinician Scientist Fellowship, NIHR
  • 2008 CCST in Neurology, JCHMT (UK)
  • 2001- 2004 Wellcome Trust Clinical Research Fellowship, Wellcome Trust
  • 1998 MRCP (UK), Royal College of Physicians
  • 1995 (German Postgraduate Medical Degree), RWTH Aachen
  • 1994 German Medical State Examination, Deutsche Arztekammer

Ursula Schulz

D.Phil MRCP (UK)

Consultant Neurologist

  • Centre for the Prevention of Stroke and Dementia

Research Summary

Dr Schulz is a Consultant Neurologist at the John Radcliffe Hospital and has an honorary agreement with the Nuffield Department of Clinical Neurosciences (Centre for the Prevention of Stroke and Dementia). She is based in the Acute Multidisciplinary Imaging and Interventional Centre (AMIIC). Her main research interest is MR-imaging after TIA and minor stroke. She studies the clinical usefulness of established MRI-techniques and also explores possible clinical applications for newly developed MR-sequences in close collaboration with the centre for functional MRI of the brain (FMRIB). Dr Schulz is particularly interested in patients with posterior circulation disease, their prognosis and risk factors. In addition to conducting clinical and imaging studies, she is also the main investigator for the Vertebral Artery Ischaemia Stenting Trial (VIST) in Oxford. This multi-centre trial compares best medical treatment versus best medical treatment plus intervention (stenting or angioplasty) in patients with a recently symptomatic vertebral artery stenosis.